Menu Back to DIA-Middle-East


Building on the accomplishments of DIA’s Regional Annual Meetings and on the collaborative initiatives developed in the Middle East region since 1996, the 1st edition of DIA Middle East will provide a key neutral platform to promote dialogue, drive collaboration and advance solutions amongst the key stakeholders in the region – from Health Authorities representatives to Industry leaders, Academia and Patients, among others.

DIA Middle East is the knowledge hub between science, healthcare, and regulation – and the place to meet trusted colleagues and make new connections with the brightest minds passionate about advancing health priorities in the region. With topics ranging from Regulatory Strategy and Convergence to Pharmacovigilance, Innovation and Clinical Development, DIA Middle East will provide a prime platform for constructive discussions and collaboration throughout the entire drug development lifecycle.


Program Committee

  • Sara  Torgal, MPharm
    Sara Torgal, MPharm Senior Manager, Scientific Programs
    DIA, Switzerland
  • Bandar  Al Hammad
    Bandar Al Hammad Chief Pharmacist, Regulatory Affairs Department
    Saudi Food and Drug Authority (SFDA), Saudi Arabia
  • Amira Deia Younes
    Amira Deia Younes Associate Director, Regulatory Policy and Intelligence, MEA, Russia & CEE
    Abbvie, United Arab Emirates
  • Fadila  Lakkis
    Fadila Lakkis Regulatory Affairs, Intelligence & Communications Manager, Gulf
    GSK, United Arab Emirates
  • Inas  Chehimi
    Inas Chehimi Head RA Middle East & North Africa
    Novartis Pharma Services AG, United Arab Emirates
  • Catherine  Al Ashram
    Catherine Al Ashram Executive Director Regulatory Affairs & PV Lead, EEMEA
    Organon, Jordan
  • Abdulrahim  Alyahya
    Abdulrahim Alyahya Director, Regulatory Policy for Middle East, Governmental Affairs & TSO
    Biogen, Saudi Arabia
  • Ali  Al Shibly Murad
    Ali Al Shibly Murad Regulatory Affairs Senior Specialist -Levant
    MSD, Lebanon
  • Haidy  Saad
    Haidy Saad Head of Regulatory Affairs-Gulf
    Novartis, United Arab Emirates
  • Amani  Mansour, MSc
    Amani Mansour, MSc Gulf Regulatory Affairs Working Group Co-Chair & Head of Regulatory Affairs-Gulf
    Pfizer, Inc., United Arab Emirates
  • Samia Gamal Seleem, PharmD, RAC
    Samia Gamal Seleem, PharmD, RAC Scientific & Regulatory Affairs Director
    Abbvie, Egypt
  • Nadia  Zalloum
    Nadia Zalloum Regulatory Affairs Manager
    F.Hoffmann-La Roche Ltd., Jordan
  • Mounay Hussein Khafaja, PharmD, MSc
    Mounay Hussein Khafaja, PharmD, MSc Regulatory Affairs Director & Regulatory Center of Excellence, IRWG Group Chair
    Merck, Lebanon
Load More

Contact us

Registration Questions?

Send Email
+41 61 225 51 51

Digital Learning Catalog

DIA Learning: eLearning Soultions